6505--Bumetanide Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79725R0068

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Bumetanide Tablets. This acquisition falls under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is classified with Product Service Code 6505, indicating a focus on medical and pharmaceutical products. The primary objective of this procurement is to secure a reliable supply of Bumetanide Tablets, a critical pharmaceutical product used in the treatment of conditions requiring diuretic therapy. The intended outcome is to ensure that VA medical facilities have consistent access to high-quality Bumetanide Tablets to support the healthcare needs of veterans nationwide. The scope of the contract encompasses the manufacturing and delivery of these tablets in accordance with federal standards and VA requirements. Key requirements for this contract include adherence to all applicable pharmaceutical manufacturing regulations and quality assurance protocols. Contractors must demonstrate the capability to produce Bumetanide Tablets that meet the VA’s specifications for safety, efficacy, and consistency. The expected deliverables are the timely and compliant supply of Bumetanide Tablets to designated VA facilities, supporting the department’s mission to provide comprehensive healthcare services to veterans. The contracting entity for this procurement is the NAC Pharmaceuticals office (organization key: 500000036), operating under the Department of Veterans Affairs. The office is responsible for overseeing pharmaceutical acquisitions and ensuring that contracted products meet the needs of VA healthcare providers. The primary point of contact for this notice is Andrew J. Cazares, who can be reached at [email protected] or (708) 786-4990 for further information or clarification regarding the award. This procurement is an award notice, indicating that the contract has been finalized and is currently active. The opportunity was posted on January 16, 2026, and remains accessible for reference via the official SAM.gov portal (Opportunity ID: 4dda59cdfebe458a9d7762e6d3d2fcbc). No specific set-aside requirements or special considerations are noted in the provided information. Contractors interested in future opportunities of a similar nature should note the consistent elements of this procurement: the focus on pharmaceutical manufacturing, the need for compliance with federal and VA standards, and the importance of reliable product delivery to support veteran healthcare. The classification codes and contact details provided will remain relevant throughout the contract lifecycle, serving as key reference points for ongoing communication and compliance. For additional details, attachments related to the award are available through the SAM.gov notice link.